FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118713133> ?p ?o ?g. }

• W3118713133 endingPage "e205371" @default.
• W3118713133 startingPage "e205371" @default.
• W3118713133 abstract "The risk of substance use disorder (SUD) in patients with autism spectrum disorder (ASD) remains unclear.To investigate the risk of SUD in patients with ASD and its associations with comorbidities, psychotropic agents (PAs), and mortality.This retrospective, population-based, cohort study of 1 936 512 participants used data from the Taiwan National Health Insurance Research Database and was conducted from January 1, 2000, to December 31, 2015. Included participants attended at least 3 outpatient visits within the 1-year study period for symptomatic ASD as determined by the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic codes. Individuals diagnosed with ASD before 2000, those diagnosed with SUD before the first visit for ASD, and those with missing data were excluded from the analysis. Patients with ASD and non-ASD controls were matched 1:4 by age, sex, and index date.Symptomatic ASD evaluated for at least 3 outpatient visits within the 1-year study period.Adjusted hazard ratios (aHRs) with 95% CIs for SUD, including alcohol use disorder (AUD) and drug use disorder (DUD), and the risk of mortality were calculated. Data were analyzed from March 1 to July 13, 2020.A total of 6599 individuals with ASD (mean [SD] age, 11.9 [5.1] years; 5094 boys [77.2%]; mean [SD] follow-up period, 8.1 [8.3] years; median follow-up period, 4.3 [interquartile range [IQR], 2.3-5.3] years) and 26 396 controls (mean [SD] age, 12.1 [5.8] years; 20 376 boys [77.2%]; mean [SD] follow-up period, 8.6 [8.9] years; median follow-up period, 4.4 [IQR, 2.4-5.4] years) were enrolled in the study. According to multivariable-adjusted analysis, the aHRs for SUD (2.33; 95% CI, 1.89-2.87), AUD (2.07; 95% CI, 1.60-2.63), and DUD (3.00; 95% CI, 2.15-4.58) were significantly higher in the ASD group than in the non-ASD controls. The aHRs for SUD in the ASD subgroups with 1 PA (0.60; 95% CI, 0.43-0.66) and with multiple PAs (0.37; 95% CI, 0.28-0.49) were significantly lower than those in the ASD subgroup with no PAs. Comparisons between patients with ASD and non-ASD controls with the same comorbidities showed higher aHRs for SUD among patients with ASD (range, 1.17-2.55); moreover, the ASD subgroup not receiving any PAs had an aHR of 6.39 (95% CI, 5.11-7.87) for SUD when they had comorbid tic disorder and aHRs of 5.48 (95% CI, 5.12-5.70) for AUD and 5.42 (95% CI, 5.12-5.80) for DUD when they had comorbid impulse control disorder. The mortality risk was significantly higher in patients with ASD and concomitant SUD than in non-ASD controls without SUD (aHR, 3.17; 95% CI, 2.69-3.89).These findings suggest that patients with ASD are vulnerable to the development of SUD. Comorbid ASD and SUD were associated with an increase in mortality risk." @default.
• W3118713133 created "2021-01-18" @default.
• W3118713133 creator A5006136616 @default.
• W3118713133 creator A5006893740 @default.
• W3118713133 creator A5012814733 @default.
• W3118713133 creator A5017182399 @default.
• W3118713133 creator A5019382650 @default.
• W3118713133 creator A5037931997 @default.
• W3118713133 creator A5057066487 @default.
• W3118713133 creator A5061538808 @default.
• W3118713133 creator A5061626486 @default.
• W3118713133 creator A5066316401 @default.
• W3118713133 date "2021-02-01" @default.
• W3118713133 modified "2023-10-11" @default.
• W3118713133 title "Risk of Substance Use Disorder and Its Associations With Comorbidities and Psychotropic Agents in Patients With Autism" @default.
• W3118713133 cites W1976011398 @default.
• W3118713133 cites W1981548509 @default.
• W3118713133 cites W1998586703 @default.
• W3118713133 cites W2000445173 @default.
• W3118713133 cites W2014102714 @default.
• W3118713133 cites W2025736977 @default.
• W3118713133 cites W2028901651 @default.
• W3118713133 cites W2030493454 @default.
• W3118713133 cites W2041196058 @default.
• W3118713133 cites W2053450543 @default.
• W3118713133 cites W2055618311 @default.
• W3118713133 cites W2061895570 @default.
• W3118713133 cites W2066109094 @default.
• W3118713133 cites W2085047066 @default.
• W3118713133 cites W2096231758 @default.
• W3118713133 cites W2102486222 @default.
• W3118713133 cites W2140883320 @default.
• W3118713133 cites W2154692607 @default.
• W3118713133 cites W2154878037 @default.
• W3118713133 cites W2216805123 @default.
• W3118713133 cites W2275369405 @default.
• W3118713133 cites W2294100109 @default.
• W3118713133 cites W2531630191 @default.
• W3118713133 cites W2556468360 @default.
• W3118713133 cites W2561028880 @default.
• W3118713133 cites W2769544142 @default.
• W3118713133 cites W2771746771 @default.
• W3118713133 cites W2885103884 @default.
• W3118713133 cites W2899112555 @default.
• W3118713133 cites W2952203707 @default.
• W3118713133 cites W2966105455 @default.
• W3118713133 cites W3006053184 @default.
• W3118713133 cites W4205431381 @default.
• W3118713133 cites W4245545717 @default.
• W3118713133 doi "https://doi.org/10.1001/jamapediatrics.2020.5371" @default.
• W3118713133 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7783585" @default.
• W3118713133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33394019" @default.
• W3118713133 hasPublicationYear "2021" @default.
• W3118713133 type Work @default.
• W3118713133 sameAs 3118713133 @default.
• W3118713133 citedByCount "40" @default.
• W3118713133 countsByYear W31187131332021 @default.
• W3118713133 countsByYear W31187131332022 @default.
• W3118713133 countsByYear W31187131332023 @default.
• W3118713133 crossrefType "journal-article" @default.
• W3118713133 hasAuthorship W3118713133A5006136616 @default.
• W3118713133 hasAuthorship W3118713133A5006893740 @default.
• W3118713133 hasAuthorship W3118713133A5012814733 @default.
• W3118713133 hasAuthorship W3118713133A5017182399 @default.
• W3118713133 hasAuthorship W3118713133A5019382650 @default.
• W3118713133 hasAuthorship W3118713133A5037931997 @default.
• W3118713133 hasAuthorship W3118713133A5057066487 @default.
• W3118713133 hasAuthorship W3118713133A5061538808 @default.
• W3118713133 hasAuthorship W3118713133A5061626486 @default.
• W3118713133 hasAuthorship W3118713133A5066316401 @default.
• W3118713133 hasBestOaLocation W31187131331 @default.
• W3118713133 hasConcept C118552586 @default.
• W3118713133 hasConcept C119060515 @default.
• W3118713133 hasConcept C126322002 @default.
• W3118713133 hasConcept C167135981 @default.
• W3118713133 hasConcept C187212893 @default.
• W3118713133 hasConcept C201903717 @default.
• W3118713133 hasConcept C205778803 @default.
• W3118713133 hasConcept C207103383 @default.
• W3118713133 hasConcept C2778538070 @default.
• W3118713133 hasConcept C2779159551 @default.
• W3118713133 hasConcept C2908647359 @default.
• W3118713133 hasConcept C40010229 @default.
• W3118713133 hasConcept C44249647 @default.
• W3118713133 hasConcept C45827449 @default.
• W3118713133 hasConcept C71924100 @default.
• W3118713133 hasConcept C99454951 @default.
• W3118713133 hasConceptScore W3118713133C118552586 @default.
• W3118713133 hasConceptScore W3118713133C119060515 @default.
• W3118713133 hasConceptScore W3118713133C126322002 @default.
• W3118713133 hasConceptScore W3118713133C167135981 @default.
• W3118713133 hasConceptScore W3118713133C187212893 @default.
• W3118713133 hasConceptScore W3118713133C201903717 @default.
• W3118713133 hasConceptScore W3118713133C205778803 @default.
• W3118713133 hasConceptScore W3118713133C207103383 @default.
• W3118713133 hasConceptScore W3118713133C2778538070 @default.
• W3118713133 hasConceptScore W3118713133C2779159551 @default.
• W3118713133 hasConceptScore W3118713133C2908647359 @default.

• next